Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Ketamine’s non-anesthetic powers: Please wait for the science

Theodore Klug, MD
Meds
June 3, 2021
9 Shares
Share
Tweet
Share

Ketamine (colloquially called “K,” “Special K,” or “Vitamin K”) is a potent, dissociative anesthetic. More specifically, it is a nonselective NMDA antagonist that initiates a wide array of physiological effects, already having ingratiated itself to a wider audience through its potential for abuse. Once used primarily in veterinary medicine, ketamine in recent years, however, has seen its medical applications extend beyond the realm of anesthesia, with clinical options now including treatment for depression, chronic and acute pain syndromes, headache, alcohol and substance use disorders, and anosmia. Despite a seemingly endless array and number of rave patient reviews, research into ketamine’s non-anesthetic powers is somewhat limited, especially in terms of its treatment for anosmia. With the COVID-19 age creating an even greater sense of urgency in the treatment of smell loss and smell disturbances, and anywhere from 35 to 70 percent of patients experiencing anosmia or hyposmia as a result of COVID-19, larger randomized controlled clinical trials and studies will be required to determine ketamine’s overall efficacy as an agent for smell regeneration. Nevertheless, given its potential as a neuromodulator and agent for cell growth, ketamine may just be the answer doctors and patients alike are looking for to treat smell disorders.

Private ketamine treatment centers have suggested for several years now that interested patients can be cured of all of their various aches and ailments through weekly or monthly infusions. All that is required is the opening of the pocketbook. Recently published, public reviews of everyday patient encounters and even highway billboards portray an overall sense of relief from the broadest array of conditions, including status epilepticus, post-traumatic stress disorder (PTSD), bipolar disorder, fibromyalgia, and obsessive-compulsive disorder (OCD), in addition to those already mentioned above. With anosmia now surfacing and cementing itself into the forefront of popular culture and conversation, ketamine infusion centers have now not surprisingly begun to market their services to treat this new and growing patient population. But should patients trust what is being advertised here?

Both debilitating and life-altering, smell loss represents a field of otolaryngology with research still in its earliest stages. While only a handful of published studies have looked into different non-surgical treatment modalities for anosmia and hyposmia, the gold standard and ultimate remedy remains absent and non-established. Vacancies like this one have traditionally held promise for private investors and companies, like those involved in ketamine infusion, the so-called “miracle treatment.” For the patient, the difficulty comes in weighing the complex relationship between ketamine and its suppliers. Although ketamine has shown promise outside of its anesthetic effects, the hard research backing up its use and mechanism of action is debatable at best. With case reports listing anosmia as a possible side effect of ketamine use, the clinical picture becomes much foggier. Ketamine is also a lucrative business, and despite a number of animal model studies elucidating the positive connections between olfactory cells and ketamine, there is still reason to be pessimistic and wary amidst the overall sense of hope and excitement posed by ketamine and its usage across the United States.

So, my plea to the general public right now can be summed up in two words: Please wait. Having never suffered from permanent smell loss, I can only imagine and try to sympathize with patients that are going through this frustrating disease process. I also understand that regaining even a single percentage of normal smell for those who have been suffering from anosmia or hyposmia for years would in and of itself be an achievement. But the science is just not there right now. Just ask the patients who tried Zicam in their desperate attempt to achieve complete allergy resolution. They’ll tell you the same thing I am. Please. Wait.

Theodore Klug is a clinical research fellow. 

Image credit: Shutterstock.com

Prev

Organizations that nurture physicians' careers can attract and retain the best doctors

June 3, 2021 Kevin 0
…
Next

Why the pandemic will impact mental health for years, and 3 concerning side effects

June 3, 2021 Kevin 1
…

Tagged as: Psychiatry

Post navigation

< Previous Post
Organizations that nurture physicians' careers can attract and retain the best doctors
Next Post >
Why the pandemic will impact mental health for years, and 3 concerning side effects

Related Posts

  • Is social media a friend or foe of science?

    Michael Joyce, MD
  • Take politics out of science and medicine

    Allison Neitzel, MD
  • Fight gun violence with science

    Jamie Coleman, MD
  • Quality measures have gotten ahead of the science of quality measurement

    Peter Ubel, MD
  • How the science of learning salvaged my college career

    Elijah Hamm
  • As cancer patients wait, states play favorites

    Jaimie Cavanaugh, JD and Daryl James

More in Meds

  • The deadly consequences of a shortage: The Pluvicto crisis leaves metastatic prostate cancer patients in limbo

    Matt Drewes
  • The real story of Xylazine contamination in street fentanyl and how we can manage it

    Julie Craig, MD
  • The cannabis education gap: Why patients are left in the dark

    Timothy Byars
  • Are doctors ready to discuss psychedelic therapies with patients?

    Thaís Salles Araujo, MD
  • The rise and dark side of fungi: Exploring health benefits and pathogenic threats

    Sandra Vamos, EdD and Deanna Lernihan, MPH
  • Advocacy and collaboration lead to major patient safety benefits on sterile pharmaceutical compounding: a review of USP’s revisions to Chapter <797>

    Elizabeth Rebello, MD
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 2 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • What Drug Did FDA Just Approve for COVID?
  • PET Scan for Alzheimer's Dx; Predicting Colon Cancer Survival
  • What Happens When We Classify Kids' Weight as a 'Disease'?
  • Sotagliflozin Gets FDA's Blessing for Heart Failure
  • Cardiorespiratory Monitoring Can Be Telling of Outcomes in Extremely Preterm Infants

Meeting Coverage

  • No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
  • Trial Results Spark Talk of Curing More Metastatic Cervical Cancers
  • Cross-Border Collaboration Improves Survival in Pediatric Leukemia Patients
  • Monoclonal Antibody Reduced Need For Transfusions in Low-Risk MDS
  • Less-Invasive Surgery for Pancreatic Cancer Proves Safe, Effective
  • Most Popular

  • Past Week

    • A patient’s perspective on the diminishing relationship between doctors and patients

      Michele Luckenbaugh | Conditions
    • Unmasking wage disparity in health care: the truth behind the Elmhurst Hospital physician strike

      Kevin Pho, MD | KevinMD
    • Why affirmative action is crucial for health equity and social justice in medicine

      Katrina Gipson, MD, MPH | Policy
    • How electronic health records preserve patients’ legacies in the words of oncologists

      Marc Braunstein, MD, PhD | Physician
    • Unmasking the brutal reality of gun violence in America: a call to action for unity and meaningful change

      Osmund Agbo, MD | Policy
    • Emulating Michael Jordan’s winning mindset: a path to success for health care professionals and entrepreneurs

      Harvey Castro, MD, MBA | Physician
  • Past 6 Months

    • The growing threat to transgender health care: implications for patients, providers, and trainees

      Carson Hartlage | Policy
    • Breaking point: the 5 reasons American doctors are dreaming of walking away from medicine

      Amol Shrikhande, MD | Physician
    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • It’s time to replace the 0 to 10 pain intensity scale with a better measure

      Mark Sullivan, MD and Jane Ballantyne, MD | Conditions
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Revolutionize your practice: the value-based care model that reduces physician burnout

      Chandravadan Patel, MD | Physician
  • Recent Posts

    • The power of coaching for physicians: transforming thoughts, changing lives

      Kim Downey, PT | Conditions
    • Why doctors aren’t to blame for the U.S. opioid crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Raw humanity on night float: inspiring patient encounters and overcoming challenges

      Johnathan Yao, MD, MPH | Physician
    • Is AI the solution for the shortage of nephrologists? ChatGPT weighs in.

      Amol Shrikhande, MD | Tech
    • Unlocking the secrets of cancer conferences: an end-of-life counselor’s journey among pharmaceutical giants

      Althea Halchuck, EJD | Conditions
    • Why HIPAA is failing and what you need to know to protect your data [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Ketamine’s non-anesthetic powers: Please wait for the science
2 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...